Schizophrenia, the metabolic syndrome and diabetes
Holt, R.I.G., Peveler, R.C. and Byrne, C.D. (2004) Schizophrenia, the metabolic syndrome and diabetes. Diabetic Medicine, 21, (6), 515-523. (doi:10.1111/j.1464-5491.2004.01199.x).
Full text not available from this repository.
The prevalence of diabetes is increased in patients with schizophrenia. Although many reasons, including hereditary and lifestyle factors, contribute to this association, recently there has been heightened interest in the subject because of the link between the use of the newer atypical anti-psychotic drugs and the development of diabetes. These drugs cause significant weight gain and this may be one of the mechanisms by which they increase incident diabetes. The increased prevalence of diabetes among people with schizophrenia has implications for the delivery of care by psychiatrists, diabetologists and primary care.
|Subjects:||R Medicine > RC Internal medicine > RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry|
|Divisions:||University Structure - Pre August 2011 > School of Medicine > Developmental Origins of Health and Disease
University Structure - Pre August 2011 > School of Medicine > Community Clinical Sciences
|Date Deposited:||11 Apr 2006|
|Last Modified:||27 Mar 2014 18:14|
|RDF:||RDF+N-Triples, RDF+N3, RDF+XML, Browse.|
Actions (login required)